FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
NephroGenex (NASDAQ: NRX) reported Q2 EPS of ($0.72), $0.16 worse than the analyst estimate of ($0.56).
For earnings history and earnings-related data on NephroGenex (NRX) click here.
... More
